Global Psoriasis Treatment Market – Overview
This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. Approval of new biologics, increase in access for the treatment in developing market, increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis Treatment market. Increase in the incidence of Psoriasis and skin disorders, and novel pipeline drugs are some of the factors expected to drive the growth of global Psoriasis Treatment market during the forecast period.
The Psoriasis Treatment market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on products, distribution channel, therapy type and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section.
Additionally, the section comprises Porter’s Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global Psoriasis Treatment market.
This 178 -page report gives readers a comprehensive overview of the Psoriasis Treatment market. Browse through 24 data tables and 65 figures to unlock the hidden opportunities in this market.
Global Psoriasis Treatment Market – Segmentation
In this report, the market segments have been analyzed based on availability of approved products, cost-effectiveness, and preference for technological systems by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.
Based on product type, the market has been segmented into TNF Inhibitors, Vitamin D analogues or its combination, Interleukin Blockers and Others. Interleukin blockers segment is likely to be the most attractive segment in the near future due to its increasing use and its ability to act selectively by targeting the proteins. The segment is expected to grow at a highest CAGR rate during forecast period.
Based on Therapy type, the global Psoriasis Treatment market has been segmented into Topical Therapeutic Drugs, Systemic Therapeutic Drugs, Combinations of therapies & others. The market segments have been extensively analyzed based on increase in demand for the therapies, availability of the drug products, and cost of therapy and severity of the disease.
Different types of distribution channels are responsible for making the psoriasis treatment available in the market. The distribution channels are Hospital pharmacy, Retail pharmacy and the online sales. Under the distribution channel segment, hospital pharmacy plays a major role followed by retail pharmacy and online sales.
Geographically, the global Psoriasis Treatment market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa).
Companies Mentioned in the Report
The report also profiles major players in the global Psoriasis Treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Amgen Inc., Eli Lilly and Company, Novartis AG, Merck & Co., Inc., Johnson & Johnson, Pfizer, Inc., AstraZeneca, AbbVie Inc., LEO Pharma A/S and Biogen.
Get accurate market forecast and analysis on the Psoriasis Treatment market. Request a sample to stay abreast on the key trends impacting this market.
The Global Psoriasis Treatment Market has been segmented as given below:
Psoriasis Treatment Market, by Product
- TNF Inhibitors
- Vitamin D Analogues or Combinations
- Interleukin Blockers
Psoriasis Treatment Market, by Therapy
- Topical Therapeutic Drugs
- Systemic Therapeutic Drugs
Psoriasis Treatment Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
Psoriasis Treatment Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insights for decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, TMR employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Transparency Market Research
90 State Street, Suite 700, Albany, NY 12207
USA – Canada Toll Free: 866-552-3453